Payment overview · 2025
General Payments
$23.60
1 reported records · 1 companies
Healthcare provider profile · identity verified
Rayeesa Ahmad, M.D
Allopathic & Osteopathic Physicians|Family Medicine · OREGON, OH · NPI 1841633708
Verified facts
What the public records show
CMS Open Payments records show Rayeesa Ahmad, M.D received $23.60 in general payments during 2025 across 1 reported records.
Janssen Pharmaceuticals, Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc | Unresolved — no canonical attribution shown | $23.60 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $23.60 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INVEGA SUSTENNA Normalized: invega sustenna |
Drug | Janssen Pharmaceuticals, Inc | $23.60 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 736 | 193 |
| Lisinopril | Lisinopril | 377 | 106 |
| Amlodipine Besylate | Amlodipine Besylate | 311 | 88 |
| Levothyroxine Sodium | Levothyroxine Sodium | 295 | 75 |
| Gabapentin | Gabapentin | 282 | 73 |
| Omeprazole | Omeprazole | 218 | 63 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 210 | 64 |
| Tizanidine Hcl | Tizanidine Hcl | 193 | 66 |
| Furosemide | Furosemide | 192 | 49 |
| Allopurinol | Allopurinol | 191 | 53 |
| Potassium Chloride | Potassium Chloride | 175 | 47 |
| Metoprolol Tartrate | Metoprolol Tartrate | 150 | 42 |
| Fluticasone Propionate | Fluticasone Propionate | 141 | 54 |
| Metoprolol Succinate | Metoprolol Succinate | 132 | 37 |
| Trazodone Hcl | Trazodone Hcl | 130 | 33 |
| Famotidine | Famotidine | 122 | 33 |
| Pantoprazole Sodium | Pantoprazole Sodium | 120 | 35 |
| Metformin Hcl Er | Metformin Hcl | 115 | 36 |
| Losartan Potassium | Losartan Potassium | 113 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 110 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 110 | 35 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 109 | 28 |
| Carvedilol | Carvedilol | 108 | 29 |
| Simvastatin | Simvastatin | 102 | 27 |
| Buspirone Hcl | Buspirone Hcl | 100 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 99 | 29 |
| Januvia | Sitagliptin Phosphate | 96 | 31 |
| Spironolactone | Spironolactone | 96 | 16 |
| Sertraline Hcl | Sertraline Hcl | 95 | 26 |
| Metformin Hcl | Metformin Hcl | 93 | 29 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 89 | 27 |
| Levetiracetam | Levetiracetam | 79 | 12 |
| Jardiance | Empagliflozin | 75 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 73 | 17 |
| Alendronate Sodium | Alendronate Sodium | 72 | 16 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 71 | 17 |
| Tamsulosin Hcl | Tamsulosin Hcl | 71 | 21 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 66 | 15 |
| Ibandronate Sodium | Ibandronate Sodium | 63 | 26 |
| Bumetanide | Bumetanide | 61 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 61 | 13 |
| Donepezil Hcl | Donepezil Hcl | 61 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 61 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 54 | 13 |
| Eliquis | Apixaban | 53 | 13 |
| Montelukast Sodium | Montelukast Sodium | 53 | 16 |
| Topiramate | Topiramate | 53 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 48 | 15 |
| Meloxicam | Meloxicam | 47 | 20 |
| Ezetimibe | Ezetimibe | 45 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | 14 |
| Dulera | Mometasone/Formoterol | 42 | suppressed |
| Ibuprofen | Ibuprofen | 42 | 22 |
| Bupropion Hcl Sr | Bupropion Hcl | 41 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 41 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 40 | 16 |
| Baclofen | Baclofen | 38 | 17 |
| Trulicity | Dulaglutide | 37 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 34 | suppressed |
| Glimepiride | Glimepiride | 33 | 11 |
| Ozempic | Semaglutide | 33 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 32 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 32 | 15 |
| Methylprednisolone | Methylprednisolone | 32 | 30 |
| Fluoxetine Hcl | Fluoxetine Hcl | 31 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 29 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 29 | 13 |
| Clonidine Hcl | Clonidine Hcl | 28 | suppressed |
| Prednisone | Prednisone | 28 | 24 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 27 | suppressed |
| Glipizide | Glipizide | 27 | 12 |
| Ketoconazole | Ketoconazole | 27 | 15 |
| Mirtazapine | Mirtazapine | 27 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 27 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 27 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 24 |
| Atenolol | Atenolol | 26 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Klor-Con M20 | Potassium Chloride | 26 | suppressed |
| Azithromycin | Azithromycin | 25 | 23 |
| Fenofibrate | Fenofibrate Nanocrystallized | 24 | suppressed |
| Ranolazine Er | Ranolazine | 24 | suppressed |
| Sucralfate | Sucralfate | 24 | suppressed |
| Cephalexin | Cephalexin | 23 | 21 |
| Clobetasol Propionate | Clobetasol Propionate | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Nitroglycerin | Nitroglycerin | 23 | 11 |
| Tradjenta | Linagliptin | 23 | suppressed |
| Aripiprazole | Aripiprazole | 22 | suppressed |
| Myrbetriq | Mirabegron | 22 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 21 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 21 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 20 | suppressed |
| Bupropion Xl | Bupropion Hcl | 20 | suppressed |
| Ondansetron Odt | Ondansetron | 20 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 20 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Lovastatin | Lovastatin | 19 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 19 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Linzess | Linaclotide | 17 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 17 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | 16 |
| Synthroid | Levothyroxine Sodium | 16 | suppressed |
| Vascepa | Icosapent Ethyl | 16 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Mounjaro | Tirzepatide | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Nystatin | Nystatin | 15 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 15 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 14 | suppressed |
| Clonidine | Clonidine | 14 | suppressed |
| Irbesartan | Irbesartan | 14 | suppressed |
| Nifedipine Er | Nifedipine | 14 | suppressed |
| Pregabalin | Pregabalin | 14 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Invokana | Canagliflozin | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Ultra-Fine Original Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
| Rexulti | Brexpiprazole | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $23.60 · 1 records | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error